Language selection

Search

eIndex Builder - Build Package

Instructions

Documents

eIndex Builder - Build Package

Document Management

Instruction1
Instruction2
Instruction3

Select a file to load

Cross reference (required) Instruction4

General information

Instruction5
Available (required)
  • 0.1.6000 6000 - APPLICATION FOR REGISTRATION RENEWAL
  • 0.1.6003 6003 - STATEMENT OF PRODUCT SPECIFICATION FORM
  • 0.1.6005 6005- APPLICATION FOR NEW OR AMENDED REGISTRATION
  • 0.1.6006 6006- APPLICATION FOR RESEARCH PERMIT
  • 0.1.6008 6008- NOTIFICATION OF PESTICIDE RESEARCH
  • 0.1.6011 6011- FEE FORM
  • 0.1.6012 6012- APPLICATION FOR REGISTRATION OF PRIVATE LABEL
  • 0.1.6018 6018- DECLARATION OF IMPORTER OF CONTROL PRODUCT
  • 0.1.6022 6022- NOTICE OF APPLICATION TO SPECIFY/CHANGE PESTICIDE MAXIMUM RESIDUE LIMITS (MRLS)
  • 0.1.6023 6023- PROPOSED NEW USES AND / OR USES TO BE WITHDRAWN FROM THE LABEL
  • 0.1.6026 6026- CHANGE IN REGISTRANT'S NAME OR REGISTRANT
  • 0.1.6110 6110- PROPOSAL FOR A USER REQUESTED MINOR USE LABEL EXPANSION
  • 0.1.6117 PRE-SUBMISSION CONSULTATION REQUEST FORM
  • 0.1.6201 6201- APPLICATION FOR ACCEPTANCE IN THE GROWER REQUESTED OWN-USE (GROU) IMPORT PROGRAM
  • 0.1.6300 6300 - NOTIFICATION / NON-NOTIFICATION FORM
  • 0.1.7000 7000- APPLICATION FORM FOR THE INSPECTION OF CONFIDENTIAL TEST DATA
  • 0.1.7002 7002- SALES INFORMATION REPORTING FORM
  • 0.1.7003 7003- INCIDENT REPORT
  • 0.1.7007 7007 - VOLUNTARY DOMESTIC ANIMAL INCIDENT REPORT
  • 0.1.7008 7008 - VOLUNTARY ENVIRONMENT INCIDENT REPORT
  • 0.1.7009 7009- VOLUNTARY HUMAN INCIDENT REPORT
  • 0.1.7010 7010 - VOLUNTARY PACKAGING FAILURE INCIDENT REPORT
  • 0.12.1 INCIDENT REPORT ANNUAL SUMMARY
  • 0.14 TECHNICAL BULLETIN
  • 0.15.1 PRODUCT STEWARDSHIP - PLAN / PROPOSAL
  • 0.15.2 PRODUCT STEWARDSHIP - REPORT
  • 0.17 REDUCED RISK RATIONALE
  • 0.17.1 GENERAL DATA BRIDGING RATIONALE
  • 0.17.2 REDUCED FEE RATIONALE
  • 0.18 CONSENT TO DISCLOSURE
  • 0.19.2 REVIEW PANEL REPORT
  • 0.7.1 RESEARCH PROTOCOLS
  • 0.7.2 LIST OF COOPERATORS
  • 0.7.3 MAPS
  • 0.8 CORRESPONDENCE- APPLICANT - GENERAL
  • 0.8.1 CORRESPONDENCE -THIRD PARTY - GENERAL
  • 0.8.1.1 CORRESPONDENCE- JOINT REVIEW MEETING MINUTES
  • 0.8.10 LETTER(S) OF SUPPORT FOR EMERGENCY USE
  • 0.8.13 LETTER OF CONFIRMATION OF SUPPLY OF THE PRESERVATIVE SOURCE (LOC-P)
  • 0.8.14 RESPONSE TO GROU INFORMATION REQUEST
  • 0.8.2 LETTER OF SUPPORT OF URMUR
  • 0.8.20 LETTER OF SUPPORT FOR RE-EVALUATION
  • 0.8.21 LIST OF USC/USE SITE SUPPORTED
  • 0.8.22 LIST OF AVAILABLE STUDIES AND/OR STUDIES IN PROGRESS
  • 0.8.23 LETTER OF RESPONSE TO USE INFORMATION REQUEST
  • 0.8.24 COVER LETTER FOR ADDITIONAL DATA REQUIRED DURING RE-EVALUATION
  • 0.8.25 ERROR CORRECTION RESPONSE
  • 0.8.26 COVER LETTER FOR ADDITONAL DATA REQUIRED AS CONDITION FOR CONTINUING REGISTRATION
  • 0.8.27 REGISTRANT FOLLOWUP TO DECISION LETTER
  • 0.8.29.1 AFFIDAVIT- INSPECTION OF CONFIDENTIAL TEST DATA
  • 0.8.29.2 AFFIDAVIT - REPRESENTATION OF ADDITIONAL INFORMATION
  • 0.8.3 LETTER OF SUPPORT OF URMULE
  • 0.8.30.1 PPIP PRELIMINARY RESPONSE LIST
  • 0.8.30.2 PPIP APPEAL LETTER
  • 0.8.30.3 PPIP APPEAL LIST
  • 0.8.4 LETTER TO ESTABLISH MRL'S FOR IMPORTED CROPS
  • 0.8.5 RATIONALE FOR REDUCED APPLICATION FEES
  • 0.8.6 LOA- LETTER OF AUTHORIZATION OF ACCESS TO DATA
  • 0.8.7 LOA- LETTER OF AUTHORIZATION OF REPRESENTATION
  • 0.8.8 LOC - LETTER OF CONFIRMATION OF SOURCE OF SUPPLY
  • 0.8.9 CSA/UL APPROVAL LETTERS
  • 0.9 MSDS - MATERIAL SAFETY DATA SHEETS - PRODUCT
  • 0.9.1 MSDS - MATERIAL SAFETY DATA SHEETS - COMPONENTS
  • 0.9.2 FOREIGN SPECIFICATIONS
  • 1.1.1 PROPOSED LABEL - ENGLISH
  • 1.1.2 PROPOSED LABEL - FRENCH
  • 1.2.1 CORRECTED LABEL - ENGLISH
  • 1.2.2 CORRECTED LABEL - FRENCH
  • 1.3 MARKETPLACE LABEL
  • 1.4 DIRECTIONS FOR USE (FOREIGN LABEL) - FOR IMPORT MRLs
  • 1.5 FOREIGN LABEL (U.S. / OTHER)
  • 10.1 VALUE DOSSIER
  • 10.2 EFFICACY
  • 10.2.1 MODE OF ACTION (TGAI) AND DESCRIPTION OF THE PRODUCT
  • 10.2.2 DESCRIPTION OF PEST PROBLEM
  • 10.2.3 EFFICACY TRIALS
  • 10.2.3.1 SUMMARY
  • 10.2.3.2 EFFICACY: LABORATORY, GROWTH CHAMBER TRIAL
  • 10.2.3.2(A) EFFICACY: LABORATORY, GROWTH CHAMBER TRIALS - ANTIFOULING
  • 10.2.3.2(B) EFFICACY: LABORATORY, GROWTH CHAMBER TRIALS - HERBICIDES
  • 10.2.3.2(C) EFFICACY: LABORATORY, GROWTH CHAMBER TRIALS - INSECTICIDE NonPP
  • 10.2.3.2(D) EFFICACY: LABORATORY, GROWTH CHAMBER TRIALS - INSECTICIDE PP AND FUNGICIDE
  • 10.2.3.2(E) EFFICACY: LABORATORY, GROWTH CHAMBER TRIALS - MATERIAL PRESERVATIVE
  • 10.2.3.2(F) EFFICACY: LABORATORY, GROWTH CHAMBER TRIALS - WATER TREATMENT
  • 10.2.3.2(G) EFFICACY: LABORATORY, GROWTH CHAMBER TRIALS - WOOD PRESERVATIVE
  • 10.2.3.3 EFFICACY: SMALL-SCALE TRIALS (FIELD, GREENHOUSE)
  • 10.2.3.3(A) EFFICACY : SMALL SCALE TRIALS (FIELD, GREENHOUSE) ANTIFOULING
  • 10.2.3.3(B) EFFICACY : SMALL SCALE TRIALS (FIELD, GREENHOUSE) HERBICIDES
  • 10.2.3.3(C) EFFICACY : SMALL SCALE TRIALS (FIELD, GREENHOUSE) INSECTICIDE NonPP
  • 10.2.3.3(D) EFFICACY : SMALL SCALE TRIALS (FIELD, GREENHOUSE) INSECTICIDE PP AND FUNGICIDES
  • 10.2.3.3(E) EFFICACY : SMALL SCALE TRIALS (FIELD, GREENHOUSE) WOOD PRESERVATIVE
  • 10.2.3.4 EFFICACY: OPERATIONAL TRIALS
  • 10.2.3.4(A) EFFICACY: OPERATIONAL TRIALS - ANTIMICROBIAL
  • 10.2.3.4(B) EFFICACY: OPERATIONAL TRIALS - HERBICIDES
  • 10.2.3.4(C) EFFICACY: OPERATIONAL TRIALS - INSECTICIDES PP AND FUNGICIDES
  • 10.2.3.4(D) EFFICACY: OPERATIONAL TRIALS - INSECTICIDES NONPP
  • 10.2.3.4(E) EFFICACY: OPERATIONAL TRIALS - WATER
  • 10.2.4 USE HISTORY
  • 10.3 ADVERSE EFFECTS ON USE SITE
  • 10.3.1 SUMMARY TABLE
  • 10.3.2 NON-SAFETY ADVERSE EFFECTS (E.G.: TO CROP, SITE OF APPLICATION)
  • 10.3.2(A) NON-SAFETY ADVERSE EFFECTS - HERBICIDES
  • 10.3.2(B) NON-SAFETY ADVERSE EFFECTS - INSECTICIDES PP AND FUNGICIDES
  • 10.3.3 DAMAGE TO ROTATIONAL CROPS
  • 10.4 SOCIAL AND ECONOMIC IMPACT
  • 10.5 SUSTAINABILITY AND CONSIDERATION OF BENEFITS
  • 10.5.1 SURVEY OF ALTERNATIVES (CONVENTIONAL AND NON-CONVENTIONAL)
  • 10.5.2 COMPATIBILITY WITH CURRENT MANAGEMENT PRACTICES
  • 10.5.3 RESISTANCE MANAGEMENT
  • 10.5.4 CONTRIBUTION TO RISK REDUCTION
  • 10.5.5 HEALTH, SAFETY AND ENVIRONMENTAL BENEFITS
  • 10.6 OTHER STUDIES/DATA/REPORTS
  • 10.7.1 SITE USE INFORMATION
  • 10.7.2 PRODUCT USE INFORMATION
  • 12.5 FOREIGN REVIEWS
  • 12.5.10 FOREIGN REVIEWS OF VALUE
  • 12.5.2 FOREIGN REVIEWS OF CHEMISTRY REQUIREMENTS FOR TGAI OR ISP
  • 12.5.3 FOREIGN REVIEWS OF CHEMISTRY REQUIREMENT FOR EP OR MA
  • 12.5.4 FOREIGN REVIEWS OF TOXICOLOGY
  • 12.5.5 FOREIGN REVIEWS OF EXPOSURE (OCCUPATIONAL AND/OR BYSTANDER)
  • 12.5.6 FOREIGN REVIEWS OF METABOLISM/TOXICOKINETICS STUDIES
  • 12.5.7 FOOD AND/OR FEED RESIDUE STUDIES
  • 12.5.8 FOREIGN REVIEWS OF ENVIRONMENTAL CHEMISTRY AND FATE
  • 12.5.9 FOREIGN REVIEWS OF ENVIRONMENTAL TOXICOLOGY
  • 12.7 APPLICANT GENERATED STUDY REVIEWS
  • 12.7.10 APPLICANT GENERATED STUDY REVIEWS - VALUE
  • 12.7.2 APPLICANT GENERATED STUDY REVIEWS-CHEMISTRY (TGAI)
  • 12.7.3 APPLICANT GENERATED STUDY REVIEWS- CHEMISTRY (EP)
  • 12.7.4 APPLICANT GENERATED STUDY REVIEWS (TOXICOLOGY)
  • 12.7.5 APPLICANT GENERATED STUDY REVIEWS (OCCUPATIONAL / RESIDENTIAL EXPOSURE)
  • 12.7.6 APPLICANT GENERATED STUDY REVIEWS (PLANT/LIVESTOCK METABOLISM)
  • 12.7.7 APPLICANT GENERATED STUDY REVIEW (FOOD RESIDUE)
  • 12.7.8 APPLICANT GENERATED STUDY REVIEWS - ENVIRONMENTAL FATE
  • 12.7.9 APPLICANT GENERATED STUDY REVIEWS - ENVIRONMENTAL TOXICOLOGY
  • 2.0 CHEMISTRY REQUIREMENTS FOR(TGAI) OR (ISP)
  • 2.1 APPLICANT'S NAME AND OFFICE ADDRESS
  • 2.10 CANADIAN PATENT STATUS
  • 2.11 MANUFACTURING METHODS FOR THE TGAI
  • 2.11.1 MANUFACTURING SUMMARY
  • 2.11.2 DESCRIPTION OF STARTING MATERIALS
  • 2.11.3 DETAILED PRODUCTION PROCESS DESCRIPTION
  • 2.11.4 DISCUSSION OF FORMATION OF IMPURITIES
  • 2.12 SPECIFICATIONS
  • 2.12.1 ESTABLISHING CERTIFIED LIMITS
  • 2.13 PRELIMINARY ANALYSIS
  • 2.13.1 METHODOLOGY/VALIDATION
  • 2.13.2 CONFIRMATION OF IDENTITY
  • 2.13.3 BATCH DATA
  • 2.13.4 IMPURITIES OF TOXICOLOGICAL CONCERN
  • 2.14 CHEMICAL AND PHYSICAL PROPERTIES
  • 2.14.1 COLOUR
  • 2.14.10 DISSOCIATION CONSTANT
  • 2.14.11 OCTANOL/WATER PARTITION COEFFICIENT
  • 2.14.12 UV/VISIBLE ABSORPTION SPECTRA
  • 2.14.13 STABILITY (TEMPERATURE, METALS)
  • 2.14.14 STORAGE STABILITY DATA
  • 2.14.15 (pH)
  • 2.14.16 NANO-MATERIAL CHARACTERISTICS
  • 2.14.2 PHYSICAL STATE
  • 2.14.3 ODOUR
  • 2.14.4 MELTING POINT/MELTING RANGE
  • 2.14.5 BOILING POINT/BOILING RANGE
  • 2.14.6 DENSITY OR SPECIFIC GRAVITY
  • 2.14.7 WATER SOLUBILITY (MG/L)
  • 2.14.8 SOLVENT SOLUBILITY (MG/L)
  • 2.14.9 VAPOUR PRESSURE
  • 2.15 SAMPLE OF ANALYTICAL STNDS AND RES OF CONC
  • 2.16 OTHER STUDIES/DATA/REPORTS
  • 2.2 MANUFACTURER'S NAME AND OFFICE ADDRESS AND MANUFACTURING PLANT'S NAME AND ADDRESS
  • 2.3 PRODUCT TRADE NAME
  • 2.3.1 OTHER NAMES
  • 2.4 COMMON NAME
  • 2.5 CHEMICAL NAME
  • 2.6 CHEMICAL ABSTRACTS REGISTRY NUMBER
  • 2.7 STRUCTURAL FORMULA
  • 2.8 MOLECULAR FORMULA
  • 2.9 MOLECULAR WEIGHT
  • 3.0 CHEMISTRY REQUIREMENTS FOR (EP) OR (TGAI)
  • 3.1 PRODUCT IDENTIFICATION
  • 3.1.1 APPLICANT'S NAME AND OFFICE ADDRESS
  • 3.1.2 FORMULATING PLANT'S NAME AND ADDRESS
  • 3.1.3 TRADE NAME
  • 3.1.4 OTHER NAMES
  • 3.2 FORMULATION PROCESS
  • 3.2.1 DESCRIPTION OF STARTING MATERIALS
  • 3.2.2 DESCRIPTION OF THE FORMULATION PROCESS
  • 3.2.3 DISCUSSION OF THE FORMATION OF IMPURITIES OF TOXICOLOGAL CONCERN
  • 3.3.1 ESTABLISHING CERTIFIED LIMITS
  • 3.4 PRODUCT ANALYSIS
  • 3.4.1 ENFORCEMENT ANALYTICAL METHOD
  • 3.4.2 IMPURITIES OF TOXICOLOGICAL CONCERN
  • 3.5 CHEMICAL AND PHYSICAL PROPERTIES
  • 3.5.1 COLOUR
  • 3.5.10 STORAGE STABILITY DATA
  • 3.5.11 FLAMMABILITY
  • 3.5.12 EXPLODABILITY
  • 3.5.13 MISCIBILITY
  • 3.5.14 CORROSION CHARACTERISTICS
  • 3.5.15 DIELECTRIC BREAKDOWN VOLTAGE
  • 3.5.16 NANO-MATERIAL CHARACTERISTICS
  • 3.5.2 PHYSICAL STATE
  • 3.5.3 ODOUR
  • 3.5.4 FORMULATION TYPE
  • 3.5.5 CONTAINER MATERIAL AND DESCRIPTION
  • 3.5.6 DENSITY OR SPECIFIC GRAVITY
  • 3.5.7 PH
  • 3.5.8 OXIDIZING OR REDUCING ACTION (CHEMICAL INCOMPATIBILITY)
  • 3.5.9 VISCOSITY
  • 3.6 SAMPLE(S)
  • 3.7 OTHER STUDIES/DATA/REPORTS
  • 4.1 SUMMARY - TOXICOLOGY PROFILE
  • 4.2 ACUTE STUDIES - TGAI
  • 4.2.1 ACUTE ORAL
  • 4.2.2 ACUTE DERMAL
  • 4.2.3 ACUTE INHALATION
  • 4.2.4 PRIMARY EYE IRRITATION
  • 4.2.5 PRIMARY DERMAL IRRITATION
  • 4.2.6 DERMAL SENSITIZATION
  • 4.2.7 POTENTIATION - INTERACTION
  • 4.2.8 ANTIDOTE
  • 4.2.9 OTHER ACUTE STUDIES - TGAI
  • 4.3 SHORT-TERM STUDIES- TGAI
  • 4.3.1 SHORT-TERM ORAL (90 DAY) (RODENT)
  • 4.3.2 SHORT-TERM ORAL (90 DAY AND / OR 12 MONTH DOG)
  • 4.3.3 SHORT-TERM ORAL (28 DAY)
  • 4.3.4 SHORT-TERM DERMAL (90 DAY)
  • 4.3.5 SHORT-TERM DERMAL (21 / 28 DAY)
  • 4.3.6 SHORT-TERM INHALATION (90 DAY)
  • 4.3.7 SHORT-TERM INHALATION (21 / 28 DAY)
  • 4.3.8 OTHER SHORT-TERM STUDIES - TGAI
  • 4.4 LONG-TERM STUDIES - TGAI
  • 4.4.1 CHRONIC (RODENT)
  • 4.4.2 ONCOGENICITY (RODENT SPECIES 1)
  • 4.4.3 ONCOGENICITY (RODENT SPECIES 2)
  • 4.4.4 COMBINED CHRONIC/ONCOGENICITY (RODENT)
  • 4.4.5 OTHER LONG-TERM STUDIES
  • 4.5 SPECIAL STUDIES - TGAI
  • 4.5.1 MULTIGENERATION / EXTENDED ONE-GENERATION REPRODUCTION (RODENTS)
  • 4.5.10 ACUTE DELAYED NEUROTOXICITY (HEN)
  • 4.5.11 28 - DAY DELAYED NEUROTOXICITY (HEN)
  • 4.5.12 ACUTE NEUROTOXICITY (RAT)
  • 4.5.13 90 DAY NEUROTOXICITY (RAT)
  • 4.5.14 DEVELOPMENTAL NEUROTOXICITY
  • 4.5.15 IMMUNOTOXICITY
  • 4.5.2 PRENATAL DEVELOPMENTAL TOXICITY (RODENT)
  • 4.5.3 PRENATAL DEVELOPMENTAL TOXICITY (NON-RODENT)
  • 4.5.4 GENOTOXICITY: BACTERIAL REVERSE MUTATION ASSAY
  • 4.5.5 GENOTOXICITY: IN VITRO MAMMALIAN CELL ASSAY
  • 4.5.6 GENOTOXICITY: IN VITRO MAMMALIAN CLASTOGENICITY
  • 4.5.7 GENOTOXICITY: IN VIVO CYTOGENETICS
  • 4.5.8 OTHER GENOTOXICITY STUDIES
  • 4.5.9 METABOLISM/TOXICOKINETICS IN MAMMALS (LABORATORY ANIMALS)
  • 4.6 ACUTE STUDIES - EP
  • 4.6.1 ACUTE ORAL
  • 4.6.2 ACUTE DERMAL
  • 4.6.3 ACUTE INHALATION
  • 4.6.4 PRIMARY EYE IRRITATION
  • 4.6.5 PRIMARY DERMAL IRRITATION
  • 4.6.6 DERMAL SENSITIZATION
  • 4.6.7 POTENTIATION - INTERACTION
  • 4.6.8 OTHER ACUTE STUDIES - EP
  • 4.6.9 SAFETY TO TREATED ANIMALS
  • 4.7 SHORT TERM STUDIES - EP
  • 4.8 OTHER STUDIES / DATA / REPORTS INCLUDING FORMULANT DATA
  • 4.8(A) IMMUNOTOXICITY EPA 870 9550
  • 4.8(B) IMMUNOTOXICITY EPA 870 7800
  • 5.1 SUMMARY
  • 5.10 AMBIENT AIR SAMPLES (INDOOR - OUTDOOR)
  • 5.11 GLOVE/CLOTHING PENETRATION DATA
  • 5.12 EPIDEMIOLOGY
  • 5.13 PACKAGE INTEGRITY STUDY
  • 5.14 OTHER STUDIES/DATA/REPORTS
  • 5.15 DUST OFF STUDY (OR OTHER BRIDGING STUDY)
  • 5.2 USE DESCRIPTION/SCENARIO (APPLICATION AND POST APPLICATION)
  • 5.3 PESTICIDE HANDLERS EXPOSURE DATABASE ASSESSMENT /AGRICULTURAL HANDLERS EXPOSURE TASK FORCE DATABASE / OUTDOOR RESIDENTIAL EXPOSURE TASK FORCE (OR OTHER DATABASE)
  • 5.4 MIXER/LOADER/APPLICATOR - PASSIVE DOSIMETRY DATA
  • 5.5 MIXER/LOADER/APPLICATOR-BIOLOGICAL MONITORING DATA
  • 5.6 AGRICULTURAL RE-ENTRY TASK FORCE/NON-DIETARY EXPOSURE TASK FORCE (OR OTHER DATABASE)
  • 5.6(A) POST APPLICATION: PASSIVE DOSIMETRY DATA AGRICULTURAL
  • 5.6(B) POST APPLICATION: PASSIVE DOSIMETRY DATA RESIDENTIAL
  • 5.7 POST APPLICATION-BIOLOGICAL MONITORING DATA
  • 5.8 DERMAL ABSORPTION
  • 5.9 DISLOGEABLE RESIDUES (FOLIAR, SOIL AND SURFACE)
  • 5.9(A) DISLODGEABLE RESIDUES (FOLIAR, SOIL AND SURFACE) AGRICULTURAL
  • 5.9(B) DISLODGEABLE RESIDUES (FOLIAR, SOIL AND SURFACE) TURF
  • 5.9(C) DISLODGEABLE RESIDUES (FOLIAR, SOIL AND SURFACE) INDOOR SURFACE
  • 5.9D DISLODGEABLE RESIDUE (SURFACE) TREATED ARTICLES
  • 6.1 SUMMARY
  • 6.2 LIVESTOCK
  • 6.3 PLANTS
  • 6.4 OTHER STUDIES/DATA/REPORTS
  • 7.1 SUMMARY
  • 7.2 ANALYTICAL METHODOLOGY (PLANT AND/OR ANIMAL COMMODITIES)
  • 7.2.1 RESIDUE TRIAL ANALYTICAL METHODOLOGY (PLANT AND/OR ANIMAL COMMODITIES)
  • 7.2.2 ENFORCEMENT ANALYTICAL METHODOLOGY (PLANT AND/OR ANIMAL COMMODITIES)
  • 7.2.3A INTER-LABORATORY ANALYTICAL METHODOLOGY VALIDATION
  • 7.2.3B EXTRACTION EFFICIENCY - RADIO-VALIDATION
  • 7.3 FREEZER STORAGE STABILITY TESTS
  • 7.4 CROP RESIDUE DATA (FOOD AND/OR FEED COMMODITIES)
  • 7.4.1 FOOD AND/OR FEED CROP RESIDUE TRIAL STUDY
  • 7.4.2 RESIDUE DECLINE STUDY
  • 7.4.3 CONFINED CROP ROTATION TRIAL STUDY
  • 7.4.4 FIELD CROP ROTATION TRIAL STUDY
  • 7.4.5 PROCESSED FOOD/FEED
  • 7.5 ANIMAL DERIVED COMMODITIES RESIDUE DATA (FROM FEEDING OF TREATED CROPS)
  • 7.5.1 LIVESTOCK FEEDING STUDY
  • 7.6 ANIMAL DERIVED COMMODITIES RESIDUE DATA (EXTERNAL APPLICATION)
  • 7.8 OTHER STUDIES/DATA/REPORTS
  • 8.1 SUMMARY
  • 8.2 LABORATORY STUDIES
  • 8.2.1 SUMMARY OF PHYSICOCHEMICAL PROPERTIES
  • 8.2.2 ANALYTICAL METHODOLOGY (PARENT COMPOUND AND TRANSFORMATION PRODUCTS)
  • 8.2.2.1 SOIL
  • 8.2.2.2 SEDIMENT
  • 8.2.2.3 WATER
  • 8.2.2.4 BIOTA
  • 8.2.3 LABORATORY STUDIES OF TRANSFORMATION
  • 8.2.3.1 SUMMARY
  • 8.2.3.2 HYDROLYSIS
  • 8.2.3.3 PHOTOTRANSFORMATION
  • 8.2.3.3.1 SOIL
  • 8.2.3.3.2 WATER
  • 8.2.3.3.3 AIR
  • 8.2.3.4 BIOTRANSFORMATION IN SOIL
  • 8.2.3.4.2 AEROBIC SOIL 20C-30C
  • 8.2.3.4.4 ANAEROBIC SOIL (FLOODED) 20C-30C
  • 8.2.3.5 BIOTRANSFORMATION IN AQUATIC SYSTEMS
  • 8.2.3.5.4 AEROBIC WATER / SEDIMENT 20C-30C
  • 8.2.3.5.5 ANAEROBIC SEDIMENT/WATER 3C-8C
  • 8.2.3.5.6 ANAEROBIC AQUATIC SEDIMENT 20C-30C
  • 8.2.3.6 SPECIAL STUDIES RELATED TO USE-PATTERN OR FORMULATION
  • 8.2.4 LABORATORY STUDIES OF MOBILITY
  • 8.2.4.1 SUMMARY
  • 8.2.4.2 ADSORPTION / DESORPTION
  • 8.2.4.3 SOIL COLUMN LEACHING
  • 8.2.4.3.1 UNAGED SOIL
  • 8.2.4.3.2 AGED SOIL
  • 8.2.4.5 VOLATILIZATION
  • 8.2.4.6 SPECIAL STUDIES RELATED TO USE-PATTERN OR FORMULATION
  • 8.3 FIELD STUDIES OF DISSIPATION/ACCUMULATION (MAYBE SMALL OR LARGE SCALE)
  • 8.3.1 SUMMARY
  • 8.3.2 TERRESTRIAL
  • 8.3.2.1 TERRESTRIAL FIELD STUDY (CANADA)
  • 8.3.2.2 TERRESTRIAL FIELD STUDY (NORTHERN U.S.)
  • 8.3.2.3 TERRESTRIAL FIELD STUDY (OTHER)
  • 8.3.3 AQUATIC
  • 8.3.3.1 AQUATIC FIELD STUDY (CANADA)
  • 8.3.3.2 AQUATIC FIELD STUDY (NORTHERN U.S.)
  • 8.3.3.3 AQUATIC FIELD STUDY (OTHER)
  • 8.3.4 SPECIAL STUDIES RELATED TO INTENDED USE-PATTERN
  • 8.4 STORAGE, DISPOSAL AND DECONTAMINATION (TGAI AND EP)
  • 8.4.1 SUMMARY
  • 8.5 OTHER ENVIRONMENTAL FATE STUDIES (TGAI AND EP)
  • 8.6 OTHER STUDIES/DATA/REPORTS
  • 8.6.1 MONITORING
  • 8.6.2 OTHER
  • 9.1 SUMMARY
  • 9.2 NON-TARGET TERRESTRIAL INVERTEBRATES
  • 9.2.1 SUMMARY
  • 9.2.3 EARTHWORMS
  • 9.2.3.1 ACUTE TOXICITY - EARTHWORM
  • 9.2.3.2 CHRONIC TOXICITY
  • 9.2.4 BEES/INSECT POLLINATORS
  • 9.2.4.1 BEE ADULT ACUTE CONTACT TOXICITY
  • 9.2.4.2 BEE ADULT ACUTE ORAL TOXICITY
  • 9.2.4.3 BEE LARVAE TOXICITY
  • 9.2.4.4 BEE ADULT CHRONIC TOXICITY
  • 9.2.4.5 BEE TOXICITY OF RESIDUES ON FOLIAGE
  • 9.2.4.6 SEMI-FIELD STUDIES FOR POLLINATORS
  • 9.2.4.7 FIELD STUDIES FOR POLLINATORS
  • 9.2.4.8 RESIDUE STUDIES FOR POLLINATORS
  • 9.2.4.9 OTHER POLLINATOR STUDIES
  • 9.2.5 PREDATORS
  • 9.2.6 PARASITOIDS
  • 9.2.7 OTHER TERRESTRIAL INVERTEBRATES
  • 9.2.8 LABORATORY STUDIES
  • 9.2.9 FIELD STUDIES
  • 9.3 NON-TARGET FRESHWATER INVERTEBRATES
  • 9.3.1 SUMMARY
  • 9.3.2 DAPHNIA SP. ACUTE
  • 9.3.3 DAPHNIA SP. CHRONIC (LIFE-CYCLE)
  • 9.3.4 LABORATORY STUDIES WITH OTHER SPECIES
  • 9.3.5 LABORATORY STUDIES
  • 9.3.6 FIELD STUDIES
  • 9.4 NON-TARGET MARINE INVERTEBRATES
  • 9.4.1 SUMMARY
  • 9.4.2 ACUTE (CRUSTACEAN)
  • 9.4.3 MOLLUSK EMBRYO LARVAE
  • 9.4.4 MOLLUSK SHELL DEPOSITION
  • 9.4.5 CHRONIC (MOLLUSK OR CRUSTACEAN)
  • 9.4.6 LABORATORY STUDIES
  • 9.4.7 FIELD STUDIES
  • 9.4.8 BIOCONCENTRATION/DEPURATION (BIVALVE OR CRUSTACEAN)
  • 9.5 FISH
  • 9.5.1 SUMMARY
  • 9.5.2 ACUTE STUDIES
  • 9.5.2.1 COLD WATER FISH (RAINBOW TROUT)
  • 9.5.2.2 WARM WATER FISH (BLUEGILL SUNFISH)
  • 9.5.2.3 OTHER FRESHWATER FISH SPECIES
  • 9.5.2.4 MARINE/ESTUARINE FISH
  • 9.5.2.4.1 SALINITY CHALLENGE
  • 9.5.3 SUBLETHAL AND CHRONIC STUDIES
  • 9.5.3.1 FISH, EARLY LIFE CYCLE TOX. TEST
  • 9.5.3.2 FISH, LIFE CYCLE TOX. TEST
  • 9.5.4 LABORATORY STUDIES
  • 9.5.5 FIELD STUDIES
  • 9.5.6 BIOCONCENTRATION
  • 9.6 WILD BIRDS
  • 9.6.1 SUMMARY
  • 9.6.2 ACUTE STUDIES
  • 9.6.2.1 ORAL (LD50) BOBWHITE QUAIL
  • 9.6.2.2 ORAL (LD50) MALLARD DUCK
  • 9.6.2.3 ORAL (LD50) OTHER SPECIES
  • 9.6.2.4 DIETARY (LC50) BOBWHITE QUAIL
  • 9.6.2.5 DIETARY (LC50) MALLARD DUCK
  • 9.6.2.6 DIETARY (LC50) OTHER SPECIES
  • 9.6.3 CHRONIC STUDIES
  • 9.6.3.1 AVIAN REPRODUCTION BOBWHITE QUAIL
  • 9.6.3.2 AVIAN REPRODUCTION MALLARD DUCK
  • 9.6.3.3 AVIAN REPRODUCTION OTHER SPECIES
  • 9.6.4 LABORATORY STUDIES
  • 9.6.5 FIELD STUDIES
  • 9.6.6 SPECIAL STUDIES RELATED TO THE INTENDED USE PATTERN (TGAI AND EP)
  • 9.7 WILD MAMMALS
  • 9.7.1 SUMMARY
  • 9.7.2 FIELD STUDIES
  • 9.8 NON-TARGET PLANTS
  • 9.8.1 SUMMARY
  • 9.8.2 FRESH WATER ALGAE
  • 9.8.3 MARINE ALGAE
  • 9.8.4 TERRESTRIAL VASCULAR PLANTS
  • 9.8.5 AQUATIC VASCULAR PLANTS
  • 9.8.6 LABORATORY STUDIES - NON TARGET PLANTS
  • 9.8.7 FIELD STUDIES
  • 9.9 OTHER STUDIES/DATA/REPORTS
  • M1.1 LABEL
  • M1.2 PRODUCT PROFILE AND PROPOSED USE PATTERN
  • M1.3 INTERNATIONAL REGULATORY STATUS OF THE MPCA AND EP
  • M10.0 VALUE (INCLUDING EFFICACY)
  • M10.1 SUMMARY
  • M10.2 PERFORMANCE ASSESSMENT
  • M10.2.1 LAB OR GROWTH CHAMBER STUDIES
  • M10.2.2 FIELD STUDIES
  • M10.3 TREATMENT EFFECTS
  • M10.3.1 PHYTOTOXICITY AND PHYTOPATHOGENICITY
  • M10.3.2 COMPATIBILITY WITH CROP PROTECTION AND MANAGEMENT PRACTICES
  • M10.3.2.1 EFFECTS ON MPCA PERFORMANCE
  • M10.3.2.2 EFFECTS OF THE EP
  • M10.4 CROP OR RESOURCE PRODUCTION BENEFITS
  • M10.4.1 PROFILE OF THE EP
  • M10.4.2 NATURE AND ECONOMICS OF PEST OR DISEASE PROBLEM IN CANADA
  • M10.4.3 CURRENT CROP PROTECTION TOOLS AND PRACTICES
  • M10.4.4 CONTRIBUTION TO IPM STRATEGIES AND PRACTICES
  • M10.5 OTHER STUDIES AND DATA
  • M12 SUMMARIES
  • M12.5 FOREIGN REVIEWS
  • M12.5.10 FOREIGN REVIEWS OF VALUE
  • M12.5.2 FOREIGN REVIEWS OF PRODUCT CHARACTERIZATION AND ANALYSIS
  • M12.5.4 FOREIGN REVIEWS OF HUMAN HEALTH AND SAFETY TESTING
  • M12.5.5 FOREIGN REVIEWS OF EXPOSURE (OCCUPATIONAL AND/OR BYSTANDER)
  • M12.5.7 FOREIGN REVIEWS OF FOOD AND FEED RESIDUES
  • M12.5.8 FOREIGN REVIEWS OF ENVIRONMENTAL FATE STUDIES
  • M12.5.9 FOREIGN REVIEWS OF ENVIRONMENTAL TOXICOLOGY
  • M12.7 COMPREHENSIVE DATA SUMMARIES
  • M2.0 PRODUCT CHARACTERIZATION AND ANALYSIS
  • M2.1 NAME AND ADDRESS OF APPLICANT
  • M2.10 ANALYTICAL DATA AND METHODOLOGY
  • M2.10.1 ACTIVE INGREDIENT OR MPCA
  • M2.10.2 ANALYSIS FOR MICROBIAL CONTAMINANTS
  • M2.10.3 ANALYSIS FOR THE OTHER UNINTENTIONAL INGREDIENTS
  • M2.11 STORAGE STABILITY TESTING
  • M2.12 SUMMARY OF PHYSICAL AND CHEMICAL PROPERTIES
  • M2.13 CHARACTERIZATION AND ANALYSIS REQUIREMENTS FOR NEW EPs OF REGISTERED MPCAs
  • M2.14 OTHER STUDIES AND DATA
  • M2.2 NAME AND ADDRESS OF MANUFACTURING PLANT
  • M2.3 NAME AND ADDRESS OF FORMULATING PLANT
  • M2.4 TRADE NAME
  • M2.5 BINOMINAL NAME (MPCA)
  • M2.6 CANADIAN PATENT STATUS INFORMATION
  • M2.7 CHARACTERIZATION OF THE MPCA
  • M2.7.1 ORIGIN, DERIVATION, AND IDENTIFICATION OF MPCA(S)
  • M2.7.2 BIOLOGICAL PROPERTIES OF MPCA(S)
  • M2.7.3 CHARACTERIZATION OF THE MPCAs DERIVED THROUGH RECOMBINANT NUCLEIC ACID TECHNOLOGIES
  • M2.7.3.1 TAXONOMY AND CHARACTERIZATION OF HOST AND DONOR MICROORGANISMS
  • M2.7.3.2 CONSTRUCTION OF THE RECOMBINANT MICROORGANISM
  • M2.7.3.3 NATURE AND EXPRESSION OF INTRODUCED OR MODIFIED GENETIC MATERIAL
  • M2.7.3.4 PHENOTYPIC CHARACTERIZATION OF THE MODIFIED MICROORGANISM
  • M2.8 MANUFACTURING METHODS AND QUALITY ASSURANCE
  • M2.9 DISCLOSURE OF INGREDIENTS
  • M2.9.1 PRODUCT SPECIFICATIONS
  • M2.9.2 POTENCY ESTIMATION AND PRODUCT GUARANTEE
  • M2.9.3 UNINTENTIONAL INGREDIENTS
  • M4.0 HUMAN HEALTH AND SAFETY TESTING
  • M4.1 SUMMARY
  • M4.2 INFECTIVITY AND TOXICITY
  • M4.2.1 SUMMARY
  • M4.2.2 ACUTE ORAL INFECT AND TOXICITY
  • M4.2.3 ACUTE PULMONARY INFECT AND TOXICITY
  • M4.3 ACUTE INFECTIVITY (IV OR IP)
  • M4.3.1 SUMMARY
  • M4.3.2 IV INFECTIVITY (E.G. BACTERIAL OR VIRAL)
  • M4.3.3 INTRAPERITONEAL INFECTIVITY (E.G. FUNGAE OR PROTOZOA)
  • M4.4 ACUTE DERMAL TOXICITY
  • M4.5 IRRITATION
  • M4.5.1 SUMMARY
  • M4.5.2 DERMAL IRRITATION STUDY
  • M4.6 REPORTING OF HYPERSENSITIVITY INCIDENCE
  • M4.7 TISSUE CULTURE (VIRAL AGENTS ONLY)
  • M4.8 GENOTOXIC POTENTIAL
  • M4.9 OTHER STUDIES AND DATA
  • M5.0 EXPOSURE ASSESSMENT
  • M7.0 FOOD AND FEED RESIDUE STUDIES
  • M8.0 ENVIRONMENTAL FATE
  • M8.1 SUMMARY
  • M8.2 LABORATORY STUDIES
  • M8.2.1 PURE CULTURE TESTING
  • M8.2.2 MICROCOSM TESTING
  • M8.3 GREENHOUSE STUDIES
  • M8.4 FIELD STUDIES
  • M8.5 OTHER STUDIES AND DATA
  • M9.0 ENVIRONMENTAL TOXICOLOGY
  • M9.1 SUMMARY
  • M9.2 BIRDS
  • M9.2.1 AVIAN ORAL TOXICITY
  • M9.2.2 AVIAN PULMONARY, INHALATION OR INJECTION
  • M9.3 WILD MAMMALS
  • M9.4 FISH
  • M9.4.1 FRESH WATER FISH
  • M9.4.2 ESTUARINE OR MARINE FISH
  • M9.5 ARTHROPODS
  • M9.5.1 TERRESTRIAL ARTHROPODS
  • M9.5.2 AQUATIC ARTHROPODS
  • M9.6 NON-ARTHROPODS INVERTEBRATES
  • M9.7 MICROORGANISMS
  • M9.8 PLANTS
  • M9.8.1 TERRESTRIAL PLANTS
  • M9.8.2 AQUATIC PLANTS
  • M9.9 OTHER STUDIES AND DATA
    Instruction6
    Instruction7
    Instruction8
    Instruction9
    Is this document published or publicly available? (required) Instruction10
    Instruction11
    Instruction12
    Instruction13
    Instruction14
    Instruction15
    Instruction16
    Instruction17

    PMRA handling

    Owned by a 3rd party? Instruction18
    Instruction19
    Multiple owners? Instruction20
    Instruction21

    Additional information

    Instruction22

    Save

    An error has occurred. This application may no longer respond until reloaded. Reload 🗙